NEOS Investment Management LLC Takes Position in Waters Co. (NYSE:WAT)

NEOS Investment Management LLC purchased a new position in shares of Waters Co. (NYSE:WATFree Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 839 shares of the medical instruments supplier’s stock, valued at approximately $276,000.

Several other large investors have also bought and sold shares of the business. IMPACTfolio LLC lifted its stake in shares of Waters by 4.2% in the 4th quarter. IMPACTfolio LLC now owns 803 shares of the medical instruments supplier’s stock valued at $264,000 after purchasing an additional 32 shares during the period. Mountain Pacific Investment Advisers Inc. ID grew its position in shares of Waters by 0.3% during the 4th quarter. Mountain Pacific Investment Advisers Inc. ID now owns 11,469 shares of the medical instruments supplier’s stock worth $3,776,000 after buying an additional 34 shares during the period. Hohimer Wealth Management LLC increased its stake in shares of Waters by 2.7% in the 4th quarter. Hohimer Wealth Management LLC now owns 1,354 shares of the medical instruments supplier’s stock valued at $446,000 after acquiring an additional 35 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. raised its position in shares of Waters by 3.6% in the 4th quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,413 shares of the medical instruments supplier’s stock valued at $465,000 after acquiring an additional 49 shares during the period. Finally, Sequoia Financial Advisors LLC boosted its stake in Waters by 5.6% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 937 shares of the medical instruments supplier’s stock worth $257,000 after acquiring an additional 50 shares during the last quarter. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Waters Stock Performance

Shares of NYSE WAT opened at $300.82 on Friday. Waters Co. has a 52 week low of $231.90 and a 52 week high of $367.21. The company has a debt-to-equity ratio of 1.60, a quick ratio of 1.30 and a current ratio of 1.94. The stock has a 50 day moving average price of $327.55 and a 200 day moving average price of $322.57. The stock has a market capitalization of $17.84 billion, a PE ratio of 29.52, a price-to-earnings-growth ratio of 4.89 and a beta of 0.97.

Waters (NYSE:WATGet Free Report) last announced its quarterly earnings data on Tuesday, May 7th. The medical instruments supplier reported $2.21 EPS for the quarter, beating analysts’ consensus estimates of $2.10 by $0.11. The company had revenue of $636.80 million during the quarter, compared to the consensus estimate of $635.57 million. Waters had a net margin of 20.75% and a return on equity of 66.59%. The company’s quarterly revenue was down 7.0% on a year-over-year basis. During the same quarter last year, the firm posted $2.49 EPS. Analysts predict that Waters Co. will post 11.85 earnings per share for the current fiscal year.

Insider Buying and Selling at Waters

In other news, Director Christopher A. Kuebler sold 4,000 shares of Waters stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $361.64, for a total transaction of $1,446,560.00. Following the completion of the transaction, the director now directly owns 14,716 shares in the company, valued at approximately $5,321,894.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Waters news, Director Linda Baddour sold 500 shares of the firm’s stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $355.54, for a total transaction of $177,770.00. Following the completion of the sale, the director now directly owns 2,250 shares in the company, valued at $799,965. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Christopher A. Kuebler sold 4,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 15th. The shares were sold at an average price of $361.64, for a total value of $1,446,560.00. Following the completion of the transaction, the director now directly owns 14,716 shares in the company, valued at approximately $5,321,894.24. The disclosure for this sale can be found here. Corporate insiders own 0.82% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have commented on WAT. Evercore ISI upped their target price on shares of Waters from $320.00 to $340.00 and gave the company an “in-line” rating in a research note on Thursday, April 4th. Robert W. Baird dropped their price objective on Waters from $319.00 to $312.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 8th. Jefferies Financial Group started coverage on Waters in a research note on Monday. They issued a “hold” rating and a $320.00 target price for the company. TD Cowen raised their price target on Waters from $350.00 to $358.00 and gave the stock a “hold” rating in a research report on Wednesday, May 8th. Finally, Barclays decreased their price objective on Waters from $300.00 to $295.00 and set an “underweight” rating for the company in a research report on Wednesday, May 8th. One research analyst has rated the stock with a sell rating and eleven have given a hold rating to the stock. Based on data from MarketBeat, Waters currently has an average rating of “Hold” and a consensus target price of $307.20.

Get Our Latest Analysis on Waters

Waters Profile

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

See Also

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.